The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 20, 2009
Filed:
Apr. 09, 2003
Kiyoshi Ando, Chigasaki, JP;
Tomomitsu Hotta, Nagoya, JP;
Chie Ito, Isehara, JP;
Hidenao Sato, Tokyo, JP;
Akiko Furuya, Tokyo, JP;
Kenya Shitara, Tokyo, JP;
Seiji Sugimoto, Tokyo, JP;
Hiroaki Kohno, Sunto-gun, JP;
Kiyoshi Ando, Chigasaki, JP;
Tomomitsu Hotta, Nagoya, JP;
Chie Ito, Isehara, JP;
Hidenao Sato, Tokyo, JP;
Akiko Furuya, Tokyo, JP;
Kenya Shitara, Tokyo, JP;
Seiji Sugimoto, Tokyo, JP;
Hiroaki Kohno, Sunto-gun, JP;
Tokai University, Tokyo, JP;
Kyowa Hakko Kogyo Co., Ltd., Tokyo, JP;
Kyowa Medex Co., Ltd., Tokyo, JP;
Abstract
The present invention relates to a method for diagnosing leukemia, pre-leukemia or aleukemic malignant blood diseases, a method of discriminating leukemia from pre-leukemia or aleukemic malignant blood diseases, a method of discriminating aplastic anemia from myelodysplastic syndrome, a method of diagnosing delayed engraftment of the hematopoietic stem cells after transplantation of the hematopoietic stem cells, and a method of diagnosing the graft versus host disease, each of said methods comprising quantifying stem cell growth factor (SCGF). The present invention also makes it possible to provide an agent for diagnosing leukemia, pre-leukemia or aleukemic malignant blood diseases and an agent for diagnosing delayed engraftment of the hematopoietic stem cells after transplantation of the hematopoietic stem cells or an agent for diagnosing graft versus host disease (GVHD), each containing as an active ingredient an antibody reacting with stem cell growth factor (SCGF).